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Purpose: To develop a first principle and multi-scale model for normal tissue complication
probability (NTCP) as a function of dose and LET for proton and in general for particle therapy with
a goal of incorporating nano-scale radio-chemical to macro-scale cell biological pathways, spanning
from initial DNA damage to tissue late effects.
Methods: The method is combination of analytical and multi-scale computational steps including
(1) derivation of functional dependencies of NTCP on DNA driven cell lethality in nanometer and
mapping to dose and LET in millimeter, and (2) 3D-surface fitting to Monte Carlo data set generated
based on post radiation image change and gathered for a cohort of 14 pediatric patients treated by
scanning beam of protons for ependymoma. We categorize voxel-based dose and LET associated
with development of necrosis in NTCP.
Result: Our model fits well the clinical data, generated for post radiation tissue toxicity and
necrosis. The fitting procedure results in extraction of in-vivo radio-biological α-β indices and their
numerical values.
Discussion and conclusion: The NTCP model, explored in this work, allows to correlate the
tissue toxicities to DNA initial damage, cell lethality and the properties and qualities of radiation,
dose and LET.
PACS numbers:
I. INTRODUCTION
It is highly challenging in radiation therapy to treat
patients and target tumors without involving and risking
normal tissues in the surrounding volumes. Optimiza-
tion of patient treatment plans allows minimizing poten-
tial harms to normal structures and in particular critical
tissues while maximizing the conformity of prescribed ra-
diation dose.
Hence, optimization processes of the patient treatment
plans rely on two objectives: (1) maximizing tumor con-
trol probability (TCP) and (2) minimizing normal tissue
complication probability (NTCP).
In proton therapy, and in general, particle therapy, de-
posited dose and LET are two mechanistic variables that
TCP and NTCP depend on. Any (personalized) model as
such must constitute radio-biological responses of tissues
throughout hierarchical stochastic and complex pathways
that starts from initial DNA damage and subsequently
being expressed in cell death machinery [1].
Thus a multi-objective optimization technique rely on
precise knowledge in spatial distribution of dose and LET
in tumors and surrounding tissues, implemented in a re-
liable and accurate multi-scale radio-biological response
theory and model. The gold standard in retrieving this
information in former is the Monte Carlo simulation of
clinical beams over patient’s data and CT images [2,3].
The latter (radio-biological response theory) requires de-
veloping multi-scale models that span over several orders
of magnitude in time and space, i.e., from 10−18s to 108s
and 1 nm to 1 cm respectively, to capture the post ra-
diation physiological pathways from initial DNA damage
to tissue late effects as the current NTCP models [4–8]
do not capture adequately these essential biological path-
ways in great details, in particular the dependencies on
LET. A model as such, was recently developed and used
for the present analysis as shown in Fig. 1.
It is known that the relative LET is typically high in
low dose volumes in tissues such as penumbras in open
fields and regions proximal and distal to Bragg peaks.
However, whether or not variabilities in LET is one of
the predictors of NTCP (in addition to dose) is still un-
der scrutiny. Besides practical challenges in low dose
measurement techniques and scoring post-radiation phe-
notypes in medical images and correlating these effects
to in-vivo radio-biological pathways, the current NTCP
models [4–8] lack adequate details in offering conclusive
and precise connections to LET. The present study is an
attempt to fill the gap between NTCP and LET from a
first-principle point of view.
In this study, we report developing a multi-scale model
for NTCP. We revisit recent publication from our group
[8] that reported selective analysis of MRI-T2 FLAIR im-
ages of pediatric patients treated for ependymoma. Anal-
ysis of the images by Peeler et al. [8] aimed to correlate
the post-radiation necrosis in domains in normal tissues,
beyond the tumor location, i.e., in brainstem, and to un-
veil the effect of unwillingly exposed low doses and high
LETs and the proton RBE spatial variabilities to tissue
toxicities. The present NTCP model is a refined and im-
proved version the model employed by Peeler et al. [8], as
it considers tissue and cell death through DNA damage-
activated death machineries that initiates apoptosis and
necrosis pathways [1]. We point out that necrotic or ra-
diation induced CNS toxicity may not depend entirely on
DNA damage as neurons are post mitotic, however DNA
damage likely serves as a surrogate for additional as yet
unknown, cellular toxicities.
Our model calculation starts from recently developed
multi-scale computational platform that calculates a
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FIG. 1: Schematic diagram of multi-scale processes from mil-
limeter to micro- and nanometer. Shown in (a) a typical pa-
tient DICOM RT image in cm-scale. (b) Passage of a charged
particle (red bold arrow) through a cell nucleus in µm-scale.
Shown in (c) and (d) the track structures of the ionization pro-
cess in nano-meter scale. Shown in (e) a transient structure
of damaged DNA surrounded by water molecules and oxy-
gens. For clarity in visualization, the water and surrounding
oxygen molecules are removed from the computational box.
Atoms color code: carbon, oxygen, nitrogen, phosphorus and
hydrogen atoms are shown as cyan, red, blue, gold and white,
respectively.
probability in tissue toxicity, P , as a function of dose and
LET for scanning beam of protons [10,11]. In this model
we derived an analytical expression for P based on a sys-
tem of Markov chains in vastly different spatio-temporal
landscapes. The model starts from the time evolution of
DNA lethal lesions that is the driving force, and an in-
put to P . Computationally, we simulate the initial DNA
damage in nano-meter (nm) from event-by-event energy
loss processes that leads to chromosome aberration and
subsequently transfer the results to the cell deactivation
in micro-meter (µm) and tumor response in millimeter
(mm). Scaling up the processes from nm to mm in space,
and 10−18s to 108s in time, we derive an explicit depen-
dence of P on dose and LET in a model that constituents
essential radio-biological pathways.
In this study, we start with a general expression for P
and calculate NTCP. We then fit P and NTCP to both
in-vitro and in-vivo dataset. We then show that fitting
to clinical data allows an extraction of numerical values
of in-vivo α and β radiobiological indices.
This paper is organized as following: We present the
analytical steps of the model calculation in Sections II A
to III, in addition to the analytical relation between
NTCP and DNA-DSBs that will be discussed in Sec.
III A. In Sections IV A and IV B we illustrate the nu-
merical results based on cell survival assay in-vitro and
the 3D-surface fitting of the clinical data, respectively.
We conclude our work in Sec. IV C.
II. MATERIALS AND METHODS
A. Outline of model calculation
Fig. 2 schematically shows segments of a normal tissue,
partitioned into N virtual domains. For brevity we call
these domains, voxels. The level of radiation exposure
and direction of the beam to these normal tissue voxels
vary randomly.
As particles deposit energy, a sequence of random dam-
ages in tissue may occur. In this work we consider class
of cell damages through apoptotic / necrotic pathways,
initiated by formation of DNA damage including double
strand breaks (DSB) and more complex cross-links [1],
that in turn trigger chromosome abberations.
To calculate spatially averaged dose and LET, denoted
by Di and LETi, respectively, and simulate our clinical
proton beams in each voxel, we used our in-house Monte
Carlo (MC) toolbox. Here i is an integer number that
allows enumeration of the voxels.
We assign a probability Pi to tissue injury event in
voxel ith, with a pair of labels, 0 and 1, to denote occur-
rence of post-radiation image change. As we consider a
binary sample space in scoring random processes in tissue
injuries, 1−Pi yields a probability in no-injury. To clarify
nomenclature and terminology in this study, we consider
tissue injury in a voxel if post-radiation image change in
the same voxel is observed. Note that the occurrence in
tissue injury depends on the severities in DNA and cell
damage, hence Pi depends on Di and LETi. We further
consider Pi a continuous function of dose and LET such
that in absence of radiation, e.g., Di = LETi = 0, no
radiation injury takes place, hence Pi = 0. Moreover,
Pi increases monotonically from zero to unity as Di and
LETi increase. The details in steps and our formulation
in calculating Pi is given in the following sections.
B. Monte Carlo
As described by Peeler at al. [8], Monte Carlo (MC)
techniques were used to produce dose and LET distribu-
tions for the patient treatment plans. The plans used
for the study were originally generated in the Eclipse
treatment planning system (v9.0) and were subsequently
recalculated using an MCNPX-based in-house MC sys-
tem in order to produce dose and fluence distributions.
The MC system takes as input the DICOM files from the
TPS which it uses to create geometry specifications as
well as files defining the beam arrangement and delivery.
The design of the system has been described previously
[2,3]. These quantities were then used to calculate track-
averaged LET distributions for each of the cases. For
any given plan, which may have consisted of a primary
and one or more boost plans, the dose was calculated as
a sum and the track-averaged LET was calculated as an
average over all plans.
3Track-averaged LET was utilized in MCNPX-based
MC calculation because it would have been prohibitively
time consuming to produce the data required to calcu-
late dose-averaged LET in each voxel, as this would have
required the scoring of the energy fluence spectrum in
every voxel. The LET values, calculated from LET dis-
tributions and typically observed in full treatment plan
are low. In this region the track-averaged LET can be
an acceptable approximation of the dose-averaged LET.
For higher values of LET, the dose-averaged LET is gen-
erally greater than the track-averaged LET [9]. Were
dose-averaged LET to be used for the analysis, we would
thus expect to observe somewhat higher values of LET
for those values already on the higher end of the spec-
trum.
C. Constant P over ensemble of voxels
If all voxels were identical, we could remove the index
i from Pi and consider a constant probability P for tis-
sue injury over the entire tissue volume. Although this
is not a realistic assumption for a human tissue under
radiation of a clinical beam, but we may consider it as
a hypothetical limiting case that simplifies calculation of
NTCP.
Assertion of this assumption turns the actual tissue re-
sponse to binary-events of exposing N copies of identical
voxels to a given dose and LET, similar to flipping copies
of N identical coins (with probabilities P and 1 − P in
scoring head and tail) as Pi is independent of voxel in-
dex i. This is regardless to a location of a voxel with re-
spect to the beam source, spot size geometry, the details
in energy-loss and lineal energy distributions, in addi-
tion to inhomogeneities in tissue physiological structure.
Thus this assumption might be reasonable for NTCP in
outer space where there is no consideration in radiation
source position with respect to location of tissue.
With further assumption of weakly correlated tissue
structures in adjacent voxels, the probability in finding
a tissue with injury can be calculated by a binomial /
Bernoulli distribution
Nn =
(
N
n
)
Pn(1− P )N−n. (1)
N is the total number of segments / voxels of the normal
tissue and n is the number of voxels scored with occur-
rence of injury. Nn is a normalized distribution function,
hence
∑N
n=0Nn = 1.
Let us consider series expansion of the normalization
condition and recall the following well-known identity of
the binomial distribution
1 =
N∑
n=0
Nn =
N∑
n=0
(
N
n
)
Pn(1− P )N−n
= (1− P )N +NP (1− P )N−1
+
N(N − 1)
2!
P 2(1− P )N−2 + ...+ PN . (2)
FIG. 2: Schematically shown a tissue divided into N seg-
ments or voxels. In each segment, a deposited dose, D, and
LET is scored.
The first term in Eq.(3) represents the probability that
all N -elements of the tissue escape from injury. Sim-
ilarly the last term represents the probability that all
N -elements of the tissue experience injury. The rest of
terms in Eq.(3) are between these two extreme limits.
For example, the second and third terms in Eq.(3) repre-
sent the probabilities that exactly one and two elements
experience injury and the rest of elements experience no
injury.
In this work, we define NTCP as the probability in
which at least one element of the normal tissue experi-
ences injury. This corresponds to all terms in Eq.(3),
except the first one, hence
NTCP = 1− (1− P )N . (3)
Eq.(3) is consistent with the NTCP model introduced by
Niemierko and Goitein in Ref. 4. One may extend this
approach and construct a cluster / percolation model for
NTCP with a minimum number of injured-elements (see
for example, Ref. 7). We do not consider this extension
in the present work.
In a careful treatment plan, optimized well to lower the
probability in normal tissue injury, P is a small number
hence
NTCP =
N∑
n=1
Nn = 1− (1− P )N ≈ NP. (4)
We refer to RHS of Eq.(4), a linearized model of NTCP.
D. Graded-P
In a more clinically relevant model of NTCP, P is a
continuous function of dose and LET. Therefore one may
4apply the transformation (1 − P )N → ∏Ni=1(1 − Pi) in
Eq.(4) and extend the NTCP to the following formulation
NTCP = 1−
N∏
i=1
(1− Pi(D,LET )). (5)
In a situation where in a given voxel, e.g., jth voxel,
D = LET = 0, Pj = 0, hence NTCP = 1 −
∏N
i 6=j(1 −
Pi(D,LET )). Therefore if N −Nx voxels experience no
dose and LET we can express
NTCP = 1−
Nx∏
i=1
(1− Pi(D,LET )), (6)
where i runs over subset of voxels that experience re-
ceiving any amount of dose and LET. Here Nx is the
number of voxels, accounted for deposition of dose and
LET. Note that in voxels receiving small amount of doses
including in penumbras of open fields and volumes prox-
imal / distal to Bragg peaks, where LET is expected to
be high, P (D,LET ) should be large if LET is one of the
predictors of NTCP.
To the best of our knowledge, in NTCP models avail-
able in literature, see for example Refs. [4–8], no explicit
dependence of NTCP on LET were reported. Thus a
systematic derivation of P (D,LET ) is needed to be per-
formed. The following section is devoted to sketch careful
derivation of P as a function of dose and LET.
III. CALCULATION OF P
Center to this model is the calculation of P , a prob-
ability that a voxel in normal tissue experiences post-
radiation image change as a result of the cell lethal injury
in that voxel. We note that our approach in calculating
P is different from the approach introduced by Niemierko
and Goitein [4] and the subsequent publications intended
to refine their original approach in photon therapy (see
for example Ref. 6).
We define P , the probability in which all of the cells
in a normal-tissue element, N0, experience lethal injury.
Note that, we have no rigorous evidence, neither exper-
imentally nor theoretically, to verify if lethal injury of
all cells in a voxel is a necessary condition for the occur-
rence of the post-radiation image change in that voxel.
It is possible that occurrence of cell lethality in a sub-
set of N0 cells, e.g., number of cells less than N0, would
be a sufficient condition for scoring post-radiation im-
age change. However, because of simplicity in computa-
tion, we assume all cells in a voxel participate collectively
in post-radiation image change. Alternatively, one may
consider N0 an additional fitting parameter that varies
within 0 and the maximum number of cells in a voxel.
Such variation can be implemented voxel by voxel, how-
ever, it introduces substantial complication in computa-
tion of NTCP, hence we do not consider the effect of
variability in cell lethality per voxel and its correlations
to post-radiation image change in our current study. We
postpone to investigate it in future.
To proceed with analytical derivation of P , we first di-
vide the normal tissue element into millimeter, then to
micrometer and finally to nanometer size virtual domains
as shown schematically in Fig. 1, a representation of our
multi-scale computational platform. In Fig. 1(a) we show
a typical patient DICOM RT image in cm-scale. The pa-
tient was treated for ependymoma by a pair of lateral
scanning proton beams technique at the proton center
in our institution. The deposited dose depicted in color
codes from low (blue) to high (red) doses. In Fig. 1(b),
passage of a charged particle (red bold arrow) through
a cell nucleus in µm-scale is shown. DNA-materials and
chromosomes in cell nucleus undergo complex damages
such as DSBs. The wiggly lines are photon field propaga-
tors, a Feynman diagram representation in quantum elec-
trodynamics (QED) that describes interaction of charged
particles in scattering processes with a random site. The
site of interaction is either on DNA and/or the environ-
ment of DNA in cell nucleus. It describes disintegration
process of water molecules into Hydrogen and release of
OH-free radicals and/or oxygen molecules into reactive
oxygen species (ROS) in indirect DNA damage (the lat-
ter), or release of shell electrons localized initially in DNA
in direct damage processes (the former). In Fig. 1 (c) and
(d) the track structures of the ionization process in nano-
meter scale are shown. The ionization tracks were cal-
culated by using Geant4-DNA Monte Carlo toolkit [16],
for 1 MeV proton and 30 MeV He respectively in water.
Fig. 1 (e) shows a transient structure of DNA sur-
rounded by water molecules and oxygens at room tem-
perature after 10 ps ReaxFF molecular dynamics [14,15]
simulated in fraction of femto-second time steps right af-
ter ionization process shown in (b), (c) and (d). For
clarity in visualization, the water and surrounding oxy-
gen molecules are removed from the computational box.
In each segment a fragment of DNA is fitted. The DNA
fragment is long enough to simulate DNA damage includ-
ing DSB lesions. A typical snap-shot of distorted DNA,
as seen in Fig. 1 (e), contains one or more single strand
breaks (SSB). SSBs located within 10 base-pairs separa-
tion are considered formation of a DSB. In this figure,
damaged bases, distorted hydrogen bonds, base-stacking
are seen. Although not shown in this figure, such atom-
istic simulations reveal formation of complex ROS in cell
nucleus (in the environment of DNA) such as hydrogen-
peroxides, formed from two OH free radicals in addition
to more complex oxygen-hydrogen compounds. Atoms
color code: carbon, oxygen, nitrogen, phosphorus and
hydrogen atoms are shown as cyan, red, blue, gold and
white, respectively.
Thus the multi-scale steps in calculating number and
types of damages in DNA consists of first performing a
collision by collision following by event by event Geant4-
DNA MC simulation [16] of track structures in a voxel in
normal tissue volume, as illustrated in Fig. 1(b)-(d). In
5second step, we perform a molecular dynamic simulation
for scoring initial structural damages to DNA induced by
ionization of surrounding water and oxygen molecules to
OH· free radicals and reactive oxygen species [14,15]. See
Fig. 1(e). Subsequently, the nm-events, including DNA-
DSBs are averaged out to scale up the lethal lesions at
the cellular level to simulate the cell survival fraction.
See Fig. 1(b).
The steps involving these algebra is cumbersome but
it is straightforward to show [11]
P [n(t)] = (1− SFeff [n(t)])N0 . (7)
Here n(t) is the average number of DNA DSB’s in a cell
nucleus in a voxel (for simplicity in notations we skip
carrying voxel index i), a variable that is function of time,
t. N0 is number of cells that constitute a normal tissue
voxel, and
SFeff [n(t)] =
e(b−d)t−L[n(t)]
1 + be(b−d)t−L[n(t)]
∫ t
0
dt′e−(b−d)t′+L[n(t′)]
,(8)
is effective cell survival fraction (SF). In Eq. 8, b and d
denote the birth and death rates of cells in absence of
radiation field and
L [n(t)] =
∫ t
0
dt′
(
λL,effn(t
′) + γL,effn2(t′) + ...
)
, (9)
is average number of lethal lesions in a cell nucleus. L
is a functional integral of n(t), the average number of
DSBs in a cell that resembles the driving force in P ,
i.e., the higher n, the closer P to one. λL,eff and γL,eff
are enzymatic misrepair rates corresponding to DNA and
chromosomes lethal lesions. They are phenomenological
coefficients that can be determined by the fitting to the
experimental cell survival data. As discussed in Ref. [11],
L fits a linear-quadratic type-relation in dose with α and
β, polynomial functions of stochastic lineal-energy, y, or
its deterministic counterpart, LET, i.e., L = α(LET )D+
β(LET )D2 +O(D3). Here α = ∑qk=0 αkLET k and β =∑q−1
k=0 βkLET
k are polynomials with rank q and q − 1.
These equations exhibit interplay of sequence of events
starting from DSB induction by ionizing radiation in mi-
croscopic scale that propagate to formation of DNA dam-
age and chromosome misrepairs to a coarse-grained tu-
mor dynamical responses in macroscopic scale. These
processes govern underlying mechanisms that constitute
multi-scale formulation of the cell deactivation in proton
and hadron therapy. For more details in mathematical
derivations and steps refer to Ref. [11].
A. NTCP and SF
To simplify the mathematical expressions for calcula-
tion of NTCP, we consider a limit where SFeff can be
replaced by SF (e.g., the limit where b = d = 0, e.g.,
mature neuron cells), hence
P (D,LET ) =
(
1− e−L[n(∞)]
)N0
= (1− SF )N0 . (10)
Considering Nx voxels for normal tissue and recalling
Eq.(6)
NTCP = 1−
Nx∏
i=1
(1− Pi)
= 1−
Nx∏
i=1
(
1− (1− SFi)N0
)
. (11)
we find
NTCP ≈ 1−
Nx∏
i=1
(1− e−N0×SFi)
≈ 1−
Nx∏
i=1
e−e
−N0×SFi
≈ 1− e−
∑Nx
i=1 e
−N0×SFi
, (12)
and finally
NTCP ≈ 1− e−
∑Nx
i=1 e
−N0×e−α(LETi)Di−β(LETi)D
2
i
. (13)
B. Surface fitting
The evaluation of post-radiation image change and cat-
egorizing the voxels were assessed by our internal physi-
cian and radiologist. A binary assignment is given to
attach 0 and 1 labels to the voxels. Voxels with no im-
age change are mapped to zero, and one otherwise. To
calculate dose and LET in each voxel, the patients’ DI-
COM images were plugged in the Monte Carlo code with
a series of beam arrangements that resembles the clinical
setup in the patient’s treatment. The tissue toxicity is
therefore mapped to a two-dimensional space of dose and
LET. We then calculated a histogram for population of
voxels that were assigned for tissue toxicity. This trans-
formed voxel population within an interval of dose and
LET to a probability density per voxel, Pexp, a discrete
function of dose and LET. The histogram, hence Pexp,
was represented in a scatter-plot in a three-dimensional
space with coordinates spanned by calculated dose and
LET.
In the next step, we fitted a two-dimensional continu-
ous surface, P (D,LET ), to the scattered-points, Pexp, a
discrete function of dose and LET. The fitting procedure
was performed under a set of mathematical constraints.
We enforced the fitted surface to follow linear-quadratic
model in dose. In addition, we asserted a set of con-
ditions on the linear-quadratic α-β indices because they
follow a coupled system of power-law series in LET. Note
6that, from nano-scale DNA damage and repair model, we
found a relation between the ranks of polynomials in α
and β. Accordingly, α and β are polynomials of LET
with ranks q and q − 1 respectively. We therefore as-
serted the latter as another constraint in fitting a surface
to scatter-plot of tissue toxicity points. Subsequent to
calculation of P , we use analytical equations derived in
our model and calculate the corresponding NTCP.
The numerical values of the fitting parameters, were
calculated within an in house developed Matlab code de-
signed for an optimization algorithm in searching the best
2D surface fitted to a data set in 3D space. An itera-
tive procedure was employed to minimize the chi-square
value to obtain the optimal parameter values and per-
forming nonlinear surface fitting. The optimization core
of our approach uses the implementation of Levenberg-
Marquardt-Fletcher algorithm developed for nonlinear
least squares fitting problems.
We consider the polynomial ranks of α and β, q and
q−1 as free parameters and fit surfaces as increasing func-
tion of q until a satisfactory convergence is obtained. The
rationale for selecting q ≥ 2 stems from numerical meth-
ods in optimization and convergence of the self-consistent
P -solutions in surface fitting procedure. By increasing
the powers in the expansion, the numerical values of the
coefficients will change, however, if the change in P re-
sides within a convergence domain (chosen by the user)
the optimization stops. Although in our approach we
search for optimal surfaces to minimize chi-square val-
ues iteratively, it is known that additional metrics are
needed to evaluate the goodness of the fit. We therefore
calculate R-square, also known as coefficient of determi-
nation (COD). The numerical value of R-square for the
final fitted surface was close to 1 as the closer the fit is to
the data points, the closer R-square to be to the value of
1. It is also known that a larger value of R-square does
not necessarily mean a better fit because of the degrees
of freedom that can also affect the values. Thus we cal-
culate the adjusted R-square values to account for the
degrees of freedom.
Similarly to determine an optimal polynomial in the
fitting process of the high-throughput and high accu-
racy clonogenic in-vitro cell-survival data, hence P , we
consider a series of polynomials corresponding to q =
2, 3, 4, · · · and perform optimization for each individual
polynomial separately. A comparison based on chi-square
and SF is performed for polynomials with orders q to
q + 1. If the difference between two chi-squares, asso-
ciated with SFs, in steps q and q + 1 is lower than a
threshold value, e.g.,
∣∣χ2(q + 1)− χ2(q)∣∣ < δ, the opti-
mization stops and chi-square, SF and P corresponding
to step q + 1 are reported. In low LETs this procedure
converges to a linear polynomial in α as a function of
LET, and a constant β with no explicit dependence on
LET.
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FIG. 3: Shown P (black) and the correspondingly NTCP
(red) of 105 cells in a typical mm-size voxel calculated from
fitting to an in-vitro H460 (NSCLC) cell line as reported in
Ref.[11]. Nx ≈ 104 calculated from physical dimensions of
the plates and samples used in the experiment [17]. As LET
increases, sigmoid curves shift to lower doses (from right to
left). The arrows indicate the NTCP corresponding to P
(same LET curves). The right most juxtaposed curves corre-
spond to LETd = 0.9 - 5.1keV/µm. The rest of the curves
from right to left correspond to LETd = 10.8, 15.2, 17.7 and
19 keV/µm.
IV. RESULTS
A. Illustrative example
For illustration of our methodology we apply an ap-
proximation to Eq. 13 where explicit variation of dose
and LET over voxels can be neglected, i.e., the entire
tissue irradiated uniformly hence explicit dependence on
index i can be discarded
NTCP = 1− e−
∑Nx
i=1 Pi(D,LET )
≈ 1− e−Nx×P (D,LET ). (14)
Here
P (D,LET ) = e−N0×e
−α(LET )D−β(LET )D2
. (15)
We note that Eq. (15) was suggested to be used in calcu-
lation of NTCP by Kallman et al. [5]. See for example
Eq. (A5) in Ref.[5] and the hand waiving arguments used
for justifications this equation. Hence the mathematical
details as presented in our study, provides a more rigor-
ous derivation of similar equation introduced by Kallman
et al. [5].
Fig. 3 shows P and NTCP on the same graph for such
a situation. The numerical values of the coefficients in the
polynomial expansion of α and β for LET < 10keV/µm
turns out to be q = 1, α0 = 0.21447, α1 = 0.007 and β0 =
0.11061, reduced χ2 = 0.00487, R2(COD)= 0.99496 and
7FIG. 4: A two dimensional topograph of the clinical data
from cohort of 14 patients, recently presented by Peeler et
al. in Ref.[8]. p = 0 (the black dots) identifies the voxels
with no post-radiation image change. Similarly p = 1 (the
red dots) represent the voxels were identified with necrotic
post-radiation image change.
adjusted R2 = 0.99481. For LET > 10keV/µm, we ob-
tained q = 4 with α0 = 0.12913, α1 = 6.733×10−3, α2 =
4.563× 10−4, α3 = 3.37529× 10−5, α4 = 8.16229× 10−6
and β0 = 0.06864, β1 = 0.00202, β2 = 1.36897 × 10−4,
β3 = 3.63748×10−5, reduced χ2 = 0.007557, R2(COD)=
0.98407 and adjusted R2 = 0.92833.
The numerical results shown in Fig. 3, in particular, a
shift in sigmoid curves to lower doses as LET increases,
mimic the recently experimental data of NTCP and late
normal tissue responses in the rat spinal cord after car-
bon ion irradiation [13]. Note that in our NTCP model,
the occurrence of the late normal tissue endpoint and the
highly structured architecture of normal tissues are a pri-
ori known and the complexities in clinical side effects are
all embedded in the radiobiological response functions,
e.g., in SF , P and NTCP. The simplicity of the present
model resides in unification of normal tissues and tumor
responses with a unique underlying microscopic pathways
regardless of vastly different complexities in normal tis-
sues and tumors responses, i.e., spite of correlations be-
tween cell survival and clinical side effects in normal tis-
sues that appears much more complex than for tumors.
B. Fitting to ependymoma clinical data
We now turn to use our NTCP model and present fit-
ting of the clinical data recently reported for evidence
of variable proton biological effectiveness in pediatric pa-
tients treated for ependymoma [8]. Fig. 4 shows the
voxels based tissue toxicity of cohorts of 14 patients. The
labels 0 (the black dots) and 1 (the red dots) correspond
to voxels identified as non-necrotic and necrotic post ra-
FIG. 5: Shown P (blue) and NTCP (green) fitted to the
clinical data Peeler et al. [8] (red). Pexp is experimental prob-
ability density, obtained from histogram of a two dimensional
topograph of the clinical data from cohort of 14 patients, pre-
sented in Fig. 4.
diation image change.
The NTCP surface fitted to these clinical data is shown
in Fig. 5. Eqs. 14 and 15 were used for fitting of the
NTCP of the clinical set. The surface shown in Fig. 5
calculated based on the best fitted surface with N0 =
8 × 106 cells per voxel where the voxel size is 1.9531 ×
1.9531 × 2.5mm. We note that an averaged number of
exposed voxels for 14 patients was calculated and used for
Nx. α and β are the output from the fitting of the surface
to these data set using linear LET model, α = α0 +
α1LET and β = β0. The converged numerical results
in the fitting procedure yields α0 = 0.25669 Gy
−1, α1 =
0.01096 Gy−1/(keV/µm) and β0 ≈ 0.
To transform the clinical data from a binary form, pre-
sented in Fig. 4, to a probability, a continuous function
of dose and LET, shown by the red dots in Fig. 5, we
counted number of voxels within an interval / bin of dose
and LET, D and D + ∆D and LET and LET + ∆LET
respectively. We then calculate P = V1/(V1 + V0) where
V0 and V1 are number of voxels accounted for no necro-
sis and with necrosis within these intervals / bins. P
is therefore a normalized histogram calculated for occur-
rence of necrosis within dose and LET intervals, ∆D and
∆LET , the same P as defined in Eq. 15. After determin-
ing P from fitting procedure (blue dots in Fig. 5) to the
clinical data (red dots), we recall Eq. 14 and calculate
NTCP (the green dots).
C. Discussion and conclusion
The NTCP model, presented in this work, starts from
radiation induced DNA damage in nano-meter and scales
up to millimeter tissue damage, observable in medical im-
ages. The methodology introduced in this work allows to
8apply a general framework to study the radio-biological
effects in-vitro and/or in-vivo. We illustrated the appli-
cability of our model and presented the numerical results
of NTCP for both cell lines. The novelty of the present
approach relies on correlations among the tissue toxici-
ties, cell lethalities and radiation induced DNA damage,
besides dependencies on the radiation dose and LET.
One may critically raise questions on model valida-
tion, the computational components how to validate such
model, inter-patients statistics and the small cohorts of
14 patients that might not be adequate for the model
validation. It is also important to note that our present
analysis is based on mixture of patients voxels, sorted
based on the scored dose and LET per voxel. With 14
patients, there are large number of voxels to analyze.
This can be seen in Fig. 4 where the points are highly
dense due to large number of voxels used for fitting the
data to a surface. For a patient by patient model valida-
tion, in our preliminary fitting procedure, we divided 14
patients into two pools of training and validation dataset,
e.g., 11 and 3, 12 and 2, or 13 and 1, respectively. In the
training dataset, we performed NTCP fitting by mixing
of the voxels of patients in the training dataset and sub-
sequently tested the result against the mixed voxels of
the second pool to validate the approach. The final re-
sult presented in this manuscript, though, is based on
fitted NTCP of all 14 patients, simply because we are
limited to small number of patients. Because this work
is in progress, in the future, the model will be validated in
larger patient cohorts using published techniques and we
may be able to present the results based on two complete
separate pools of training and validation.
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